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Abstract—Africa is a continent characterized by marked ethnic, sociodemographic, and economic diversity, with profound 
changes in many regions over the past 2 decades. This diversity has an impact on cardiovascular disease presentation 
and outcomes. Within Africa and within the individual countries, one can find regions having predominantly 
communicable diseases such as rheumatic heart disease, tuberculous pericarditis, or cardiomyopathy and others having 
a marked increase in noncommunicable disease such as hypertension and hypertensive heart disease. Ischemic heart 
disease remains rare in most countries. Difficulties in the planning and implementation of effective health care in 
most African countries are compounded by a paucity of studies and a low rate of investment in research and data 
acquisition. The fiduciary responsibilities of companies working in Africa should include the effective and efficient use 
of natural resources to promote the overall health of populations. (Circulation. 2016;133:1199-1208. DOI: 10.1161/
CIRCULATIONAHA.114.008730.)
Key Words: cardiovascular diseases ◼ epidemiology
Impact of Socioeconomic Status, Ethnicity, and Urbanization 
on Risk Factor Profiles of Cardiovascular Disease in Africa
Karen Sliwa, MD, PhD, FESC, FACC; Letitia Acquah, MD, MSc;  
Bernard J. Gersh, MB, ChB, DPhil, MACC, FRCP; Ana Olga Mocumbi, MD, PhD, FESC
© 2016 American Heart Association, Inc.
Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.114.008730
From Hatter Institute for Cardiovascular Research in Africa & IDM, Department of Medicine, Faculty of Health Sciences, University of Cape Town, 
South Africa (K.S.); Soweto Cardiovascular Research Unit, University of the Witwatersrand, Johannesburg, South Africa (K.S.); Medical Research Council 
of South Africa, Inter-Cape Heart Group, Cape Town, South Africa (K.S.); Division of Hospital Internal Medicine, Department of Medicine, Mayo Clinic 
Hospitals, Rochester, MN (L.A.); Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN (B.J.G.); Instituto 
Nacional de Saúde, Maputo, Mozambique (A.O.M.); and Universidade Eduardo Mondlane, Maputo, Mozambique (A.O.M.).
Correspondence to Karen Sliwa, MD, PhD, FESC, FACC, Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Groote 
Schuur Hospital, 3 Anzio Rd, University of Cape Town, Cape Town 7935, South Africa. E-mail Karen.Sliwa-Hahnle@uct.ac.za
Cardiovascular diseases (CVDs) with infectious and nutri-tional origins have long been the principal forms of heart 
disease in Africa. In this article, we use the term CVD result-
ing from communicable causes for rheumatic heart disease, 
HIV, virus-induced cardiomyopathy, etc. For CVD resulting 
from noncommunicable causes, for example, hypertension, 
cardiomyopathy, and myocardial infarction, we use the term 
CVD resulting from noncommunicable causes.
The epidemiological transition with a subsequent increase 
in hypertension and diabetes mellitus has seen an increased 
prevalence of noncommunicable forms of heart disease 
in most African populations.1 This phenomenon is driven 
largely by population-wide changes in demographic, social, 
and economic status, with associated changes in lifestyle 
habits.2–4 Nonetheless, the incidence of communicable CVD 
is sustained and fueled by the epidemics of the HIV/AIDS, 
rheumatic heart disease, tuberculosis, and parasitic infections 
with cardiac involvement.5–7 In parallel, the rapid and marked 
increase in the prevalence of cardiovascular risk factors raises 
the spectrum of a potential epidemic of noncommunicable 
CVDs in an environment characterized by limited resources 
and infrastructure to combat these threats.
The aim of this thematic review is to describe the cur-
rent knowledge of the impact of socioeconomic status and 
its relationship with risk factor profiles on CVD and regional 
epidemiology within Africa. Furthermore, we aim to review 
current and novel strategies for disease prevention, treatment, 
and behavioral change, as well as the progress of policy devel-
opment. This is within the context of the substantial gaps in 
available data and its profound limitations. For many coun-
tries, we have either no data or only data collected within cer-
tain urban areas and certain population groups. In this article, 
we have summarized the gaps in knowledge and resources and 
our recommendations for the way forward, which we hope 
will assist in future healthcare planning.
Statistical Capacities for Gross 
Domestic Product Assessment in African 
Economies and Its Impact on Disease
The economic classification of countries has tradition-
ally been based on the gross domestic product (GDP). The 
International Monetary Fund recommends that the base 
year for GDP estimation should be updated every 5 years. 
However, as Jerven8,9 highlighted in his recent perspective 
article and book, only a few countries in Africa are able to 
fulfill that standard; for most countries, the base years are 
about a decade or older. These significant errors are high-
lighted by recent examples of Ghana and Nigeria. Ghana’s 
GDP was recalculated on the basis of a change in statistical 
methodology, and the country’s GDP was revised upward to 
such an extent that Ghana’s recorded GDP per capita almost 
doubled, leading to a reclassification from a low-income 
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country to a lower-middle-income country. This dramatic 
jump was based on changing the base year from 1993 to 
2006.8 For Nigeria, the most populous nation on the African 
continent, the base year is 1990, and a revision is underway. 
Nigeria’s economy is ≈50 times the size of that of an African 
country with one of the lowest economies, for example, 
Malawi. Doubling the estimates of the size of Nigeria’s 
economy would have an enormous impact on any economic 
assessment of the continent. The poor quality of the current 
data makes any factual statement of the current aggregate 
trends of growth and poverty and subsequent continent-
wide estimates uncertain, thus complicating the prediction 
of healthcare consequences for individual African countries. 
GDP numbers and other statistics such as health statistics, 
which we often treat as fact, bear with them the caveat that 
these are often simply numbers or estimations produced 
under the most difficult circumstances. In particular, we have 
a paucity of knowledge of those who are the poorest or live 
in the most remote regions in Africa, as is the case among 
many indigenous populations. To change that situation, we 
would need recognition of the importance of data collection, 
substantial funding, and human resources. For most African 
countries, a typical Living Standard Measurement Survey, as 
developed by the Development Research Group of the World 
Bank, to improve the type and quality of household data col-
lection by statistical offices in developing countries would 
be desirable. An e-learning course is available on their Web 
site (www.econ.worldbank.org). At present, most African 
countries do not have a specific budgetary allocation for that 
purpose because of either a lack of resources or a lack of a 
perceived need for such surveys.
Africa: A Continent Characterized by 
a Marked Ethnic, Sociodemographic, 
and Economic Diversity: Impact on 
CVD Presentation and Outcomes
Beside health surveys, a broad range of parameters are needed 
to assess the impact of economic development on cardiovas-
cular and other manifestations of disease on different African 
populations. The African continent is highly diverse ethni-
cally. This is reflected in Figure 1, which exhibits color-coded 
regions of the African continent representing the 4 phyla of 
African language families consisting of an estimated 2000 lan-
guages.10 Mother language defines ethnic groups and, to some 
extent, behavior based on traditions. Current political borders 
arise to a large extent from the colonial era and thus are not 
necessarily representative of the specific African ethnicities.
Africa has a large number of countries in the highest 
income inequality tertiles (Table 1).11 The Gini index or Gini 
Figure 1. African language families and some major African lan-
guages. Color-coded regions of the African continent represent-
ing examples of major languages derived from major language 
phyla of African language families. Adapted from image created 
by Mark Dingemanse, according to classification by Joseph 
H. Greenberg, and released under the Creative Commons 
Attribution 2.5 license.
Table 1. Analysis of 78 Countries Stratified by Income 
Inequality.
Low Gini (<0.38) Medium Gini (0.38–0.55) High Gini (>0.55)
Australia Argentina Bolivia
Austria Bangladesh Brazil
Belgium Botswana* Burkina Faso*
Canada Bulgaria Cameroon*
China Chile Central African Republic*
Denmark Costa Rica Colombia
Finland Dominica Ecuador
France Egypt* Gambia*
Great Britain El Salvador Guinea
Greece Ethiopia* Honduras
Ireland Ghana* Jamaica
Italy Guatemala Lesotho*
Japan Guyana Madagascar*
Luxembourg Indonesia Mali*
Mongolia Jordan Mauritania*
Netherlands Malaysia Mexico
New Zealand Nepal Nicaragua
Norway Nigeria* Panama
Portugal Peru Paraguay
Republic of Korea Philippines Senegal*
Romania Sri Lanka South Africa*
Spain Trinidad and Tobago Swaziland*
Sweden Turkey Thailand
Switzerland Uganda* United Republic of 
Tanzania*
United States Uruguay Zambia*
Vietnam Venezuela Zimbabwe*
Data were taken from Kim et al.11 
*African countries.
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coefficient is a measure of statistical dispersion and is used 
to represent the extent to which the distribution of consump-
tion expenditure or income per person (or household) within 
a specific society differs from a perfectly equal distribution 
and is the most commonly used measure of inequality. The 
Lorenz curve is a graphical representation of wealth or income 
distribution and is used to map the collective percentages of 
total income received against the number of recipients, begin-
ning with the individual or household with the lowest income. 
The area between the Lorenz curve and a hypothetical line of 
absolute equality is expressed as a percentage of the maxi-
mum area under the line, as defined by the Gini index. A Gini 
index of 0 indicates perfect equality, and an index of 100 
implies perfect inequality (http://data.worldbank.org/indica-
tor/SI.POV.GINI?page=5). A wide variety of Gini indexes for 
African countries means that within many African countries 
certain population groups are wealthy and experience a very 
different lifestyle, which includes access to health care, com-
pared with other population groups living in absolute poverty. 
The implications of such differences are reflected in the pro-
file of diseases encountered within the continent as a whole: A 
double burden in which communicable and noncommunicable 
diseases linked to poverty coexist with risk factors linked to 
obesity, urbanization, industrialization, and others.12
This heterogeneity in different ethnic groups within a 
country is highlighted in the INTERHEART Africa study,13,14 
reporting on the impact of education and income on risk fac-
tors for acute myocardial infarction among different ethnic 
groups living in South Africa.
A standardized case-control study of myocardial infarc-
tion, from which a total of 578 cases and 789 controls were 
recruited in the African continent (52 countries), was the basis 
of the INTERHEART Africa Study. In the black population, 
those who had <8 years of schooling as opposed to those with 
higher education showed an increased risk of acute myocardial 
infarction (odds ratio, 1.86; 95% confidence interval, 1.06–
3.25). In contrast, there was no difference observed in the col-
ored African group (odds ratio, 0.71;95% confidence interval, 
0.30–1.68). The direction of association was just the opposite 
for the European/other African groups. In these groups, those 
with tertiary education had a significantly lower risk (odds 
ratio, 0.30; 95% confidence interval, 0.15–0.58) compared 
with those who attended school for <8 years. Probability val-
ues for the interaction of education and ethnicity and for the 
income-ethnicity interaction are <0.0001 (Figure 2).
The country-level risk factor estimates for 199 coun-
tries from a systematic analysis of population-based data by 
Danaei and colleagues4 were used to analyze the trend in 
associations between per capita GDP and cardiovascular risk 
factors. A worldwide network of clinical and public health 
researchers and practitioners, the Global Burden of Metabolic 
Risk Factors of Chronic Diseases Collaborating Group, has 
identified a unique data set on 5 risk factors: body mass index 
(BMI), blood pressure, serum cholesterol, fasting plasma glu-
cose, and diabetes mellitus.
In 1980, 3 major metabolic risk factors for CVD, namely 
systolic blood pressure (SBP), total cholesterol, and BMI, were 
positively associated with income per country and Western 
diet at the national level. Re-evaluation of these factors in 
Figure 2. Impact of education and income on risk 
factors for acute myocardial infarction in different 
ethnic groups living in South Africa. Odds ratio 
(OR) associated with increasing formal education 
by ethnic group (A) and with increasing income by 
ethnic group (B). Adapted from Steyn et al.14
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2008 demonstrated that only serum cholesterol levels retained 
a strong positive association with national income.
Data from the World Health Statistics for the African 
continent are subject to considerable uncertainty. They pro-
vide estimates that are based on data from multiple source, 
with limited availability and quality as a result of the inherent 
weaknesses in the statistical and health information systems 
in many African countries. The 2012 World Health Statistics 
referring to Africa report the following:
•	 The median prevalence of raised fasting blood glucose 
(ie, fasting glucose ≥126 mg/dL [7.0 mmol/L] or taking 
medication for raised blood glucose) among adults ≥25 
years of age was 9.9% for men and 9.5% for women.
•	 The median prevalence of raised blood pressure (ie, SBP 
≥140 mm Hg or diastolic blood pressure ≥90 mm Hg) 
among adults ≥25 years of age was 34.6% for men and 
28.3% for women.
•	 The median prevalence of obesity (ie, BMI ≥30 kg/m2) 
among adults ≥20 years of age was 14.9% for men and 
22.1% for women.
These reported figures are age-standardized point esti-
mates that are adjusted for uncertainty ranges (available on 
the Global Health Observatory Web site, http://www.who.int/
gho).
In regard to the estimated prevalence of diabetes mellitus, 
there was relatively little variation across income groups and 
in different countries. This ranged from 8% in both sexes in 
low-income countries to 10% in high-middle-income coun-
tries. (http://www.who.int/nmh/publications/ncd_report2010)
The authors concluded that the changing associations 
between metabolic risk factors and macroeconomic variables 
suggested an upcoming global pandemic of hyperglycemia 
and diabetes mellitus, together with high blood pressure, in 
low-income countries regardless of income.4
Africa Cross-Country Associations of 
CVDs and Risk Factors Interlinked 
With GDP and Income Inequality
A recent series of publications in The Lancet15–18 reported 
national, regional, and global trends in the prevalence of BMI, 
serum cholesterol, plasma glucose, and SBP since 1980 in 
199 countries and territories, including data from >5 million 
participants.
Obesity prevalence in men and women varied fundamen-
tally within Africa (Figure 3A), with the prevalence of over-
weight and obese women being highest in southern Africa 
in 2008 and still remarkably low in West, East, and Central 
Africa. The prevalence rate of obesity in African men is in 
general lower than that in women.15 Serum total cholesterol in 
2008 was lowest in Sub-Saharan Africa at 4.08 mmol/L (3.82–
4.34 mmol/L) for men, and 4.27 mmol/L (3.99–4.56 mmol/L) 
for women and highest in Cameroon, Namibia, Botswana, and 
Tanzania, according to the World Health Organization (WHO) 
Infobase in 2010.16 Mean fasting plasma glucose in 2008 was 
also lowest in Sub-Saharan Africa. However, investigating the 
change in country age-standardized SBP between 1980 and 
2008 demonstrated a rise in SBP in East Africa for both sexes 
and in West Africa for women, with the increase ranging from 
0.8 to 1.6 mm Hg per decade in men and 1.0 to 2.7 mm Hg 
per decade in women. According to the WHO country-spe-
cific data on the mean prevalence rates of hypertension among 
adult men and women, the mean prevalence rates of hyperten-
sion in West (ie, 43% versus 40%) and East (ie, 40% versus 
37%) African men are higher than those in women, whereas 
those in southern African males (ie, 34% versus 40%) are 
lower than in females. The mean prevalence rates of hyperten-
sion are equal among adult northern African men and women 
(ie, 39% versus 38%).
However, the authors of the articles by the Global Burden 
of Metabolic Risk Factors of Chronic Diseases Collaborating 
Group clearly highlight that the main limitation of their 
studies is that despite extensive attempts at data collection, 
many countries do not have specific data, especially for the 
1980s.15 The absence of those data is reflected in wider uncer-
tainty intervals. In total, SBP is currently highest in low- and 
middle-income countries worldwide, including many African 
countries.
Studies have identified economic development, as mea-
sured by the GDP per capita, as a predictor of CVD risk fac-
tors. In a cross-national analysis of 85 countries, Ezzati et al23 
observed a concave and nonlinear association between GDP 
per capita, mean BMI, and serum cholesterol, with higher 
risk factor levels at intermediate (versus low) GDP levels and 
comparable to slightly lower risk factor levels at high (versus 
intermediate) GDP levels. Data were not specifically analyzed 
per region, for example, Africa.
Kim et al11 reported cross-country associations of income 
inequality with CVD and risk factors. They collected a large 
set of data from 78 countries, within which 14 of the 26 
countries in the highest inequality tertile defined by the Gini 
coefficient were located on the African continent (Table 1).11 
Income inequality is likely to have an effect on cardiovascular 
risk factors, the epidemiological transition within the different 
African countries, and the many ethnic groups living in rural 
and urban areas.
Pampel et al24 and Goyal et al25 described that although 
socioeconomic status and weight have a positive association 
in low-income countries, they have a negative association in 
higher-income countries. However, the authors introduce a 
caveat emphasizing that the relationship and its causes need to 
be tested in large and diverse national databases.
Figure 3A through 3D shows the prevalence of cardio-
vascular risk factors such as obesity, hypertension, choles-
terol, cigarette/tobacco smoking, and diabetes mellitus within 
the different regions of Africa as published from the WHO 
InfoBase, International Federation of Diabetes, and World 
Bank. It is challenging to find data on the minimum legal 
ages of smoking and, more important, the implementation and 
compliance with specific laws and regulations to address the 
worsening epidemic of tobacco and tobacco-associated ill-
nesses in various African countries. Many African countries 
have not complied fully with the Framework Convention on 
Tobacco Control. The Framework Convention on Tobacco 
Control legislates protection from tobacco smoke exposure; 
the packaging and labeling of tobacco products; and the 
advertising, promotion, and sponsorship of tobacco products. 
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In 2011, Tumwine,26 of the Health and Environmental Rights 
Organization, advocated the prioritization of resources 
for capacity building in African countries. The aim was to 
facilitate the drafting of a strong Framework Convention on 
Tobacco Control–compliant legislation that includes research 
on tobacco use in Africa with the objective of informing policy 
making and boosting the political will of African countries. 
These measures are aimed at successfully counteracting the 
Figure 3. A, Prevalence rates of adult obesity (body mass index [kg/m2]) in Africa (2005), as reported by the World Health Organization 
InfoBase, International Federation of Diabetes, and World Bank (percent of adults ≥15 years of age). Combined estimates of mean 
prevalence rates of adult obesity in males and females are color-coded in the legend. Adapted from Diabetes Federation19 with permis-
sion. B, Prevalence rates of hypertension among adults ≥15 years of age in Africa (2011), as reported by the World Health Organization 
(WHO) InfoBase, International Federation of Diabetes, and World Bank. Mean prevalence rates of hypertensive males versus females 
are indicated in blue and red, respectively. Adapted from the Non-Communicable Disease Country-Specific Profiles 2011: WHO Global 
Report.20 C, Prevalence rates of estimated mean cholesterol (mmol/L total cholesterol) in Africa (2010), as reported by the WHO InfoBase, 
International Federation of Diabetes, and World Bank. Combined estimated mean cholesterol prevalence rates (%) for males and females 
indicated by color code in the legend. Adapted from the WHO Global Comparable Estimates.21 D, Combined estimated prevalence rates 
(percent) for age- and sex-standardized cigarette smoking, as reported by the World Health Organization (WHO) InfoBase, International 
Federation of Diabetes, and World Bank. Combined age-standardized prevalence estimates of males and females who are currently 
smoking cigarettes are color-coded in the legend. Adapted from the WHO Report on the Global Tobacco Epidemic 2009: Implementing 
Smoke-Free Environments.22
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strong influence of the tobacco industry in recruiting smokers 
in African countries.
Pampel27 examined data on tobacco use among men (age, 
15–54 years) and women (age, 15–49 years) from 16 demo-
graphic health surveys in 14 Sub-Saharan countries. According 
to Pampel’s analysis, the gradation of the prevalence of ciga-
rette smoking increases from among West-Central African men 
(lowest use) to southern African men (medium use) and then to 
men from Madagascar and East-Central Africa (highest use). 
The highest prevalence of cigarette smoking was observed 
among urban, less educated men and women of lower socioeco-
nomic status, although the prevalence rates of women cigarette 
smokers were lower than the rates for their male counterparts.
The observed region-specific risk factors are quite complex 
to explain, and associations between region-specific variables 
and the prevalence rates of the cardiovascular risk factors may 
not have been definitively measured as a result of financial and 
infrastructural difficulties in designing studies to capture such 
data. However, in general, southern Africa (particularly South 
Africa), and northwest Africa, for example, Algeria, have the 
highest percentages of obesity, undiagnosed diabetes mellitus, 
smoking, and high cholesterol. SBP levels are generally high 
but particularly high in western and eastern Africa. However, 
some of the findings are puzzling, for example, the fact that the 
estimated mean cholesterol for the populations of Namibia and 
Botswana is >4.6 mmol/L (Figure 3C) and among the high-
est on the continent. Both countries have a particularly high 
proportion of people still living a rural lifestyle, for example, 
the Himba and Ovambo in northern Namibia and the Khoi-San 
in northern South Africa, Botswana, and Namibia. Many are 
herders and migrants. It is very unlikely that people belonging 
to these ethnic groups have high cholesterol. The findings used 
in this WHO global comparable estimate are probably based 
on findings from urban populations and small studies.
Mensah3 provided a descriptive epidemiology of cardio-
vascular risk factors and diabetes mellitus in Sub-Saharan 
Africa. Rising BMI, particularly in women from southern 
Africa, and high blood pressure in East Africa for both sexes 
and in West Africa for women were the most important cardio-
vascular risk factors.
Research and Development in Africa and 
Impact on CVD Research and Management
There is a link between investment in research and macroeco-
nomic growth in that the fraction of GDP that countries spend 
on research and development (R&D) is highly correlated with 
the fraction of their population who are scientists and engi-
neers.28 Technology, although not exactly a form of capital, 
is related to human and intellectual capital and is capable of 
generating positive feedback, which enables a virtuous cycle 
of exponential growth.29 To the classic factors of production 
that affect exponential economic growth, we might add vari-
ous forms of human capital such as investment in education 
and intellectual property.28
It would appear that nations who spend close to 3% of 
their GDP on R&D are usually more successful when com-
peting for economic growth opportunities than those who 
spend less.28 By world standards, despite having risen in most 
African countries between 2002 and 2008, the GDP per capita 
remains low.30 Although Africa’s contribution to global R&D 
efforts have progressed, a number of challenges, including 
budgetary/financial constraints, need to be addressed (http://
www.unesco.org/new/en/media-services/singleview/news/
research_and_development_africa_is_making_progress_
despite_major_challenges/#.VUzXis5LNfQ).
Only about 0.3% of GDP of the continent is devoted to 
R&D, which is 7 times less than that spent by industrialized 
countries on this sector. Although recent economic data show 
that Nigeria’s economy has overtaken South Africa’s to become 
the continent’s largest and the world’s 26th most productive, 
South Africa spends more on R&D. With its investment rising 
from 0.73% in 2001 to 0.97% in 2007 as a proportion of GDP, 
South Africa is the only country in the continent that comes 
close to the 1% mark for the R&D expenditure and leads in 
terms of scientific publications, with 46% of the continent’s 
entire share, far ahead of Nigeria (11.4%).30
Major challenge for R&D in Africa are the low literacy 
rate, poor quality of education, and brain drain. At least 
one third of all African researchers or those with engineer-
ing degrees were living and working in developed countries 
in 2009. Several African countries (eg, Uganda, Cameroon, 
Botswana) are striving to address this problem by increas-
ing academic’ salaries, as well as offering other incentives.30 
Nonetheless, to reach the suggested target of 1000 researchers 
per 1 million population by 2025, radical changes will need to 
be implemented.30 A fundamental issue, which will take time, 
vision, and a fundamental commitment from governments to 
be overcome, is the overall lack of resources and competing 
demands for the treatment and prevention of both communi-
cable and noncommunicable diseases. It is imperative that the 
R&D objectives be specifically focused and tailored toward 
those disease entities that are highly prevalent on the African 
continent and on issues and obstacles in regard to document-
ing their epidemiology, treatment, and prevention.
The poor state of R&D in Africa, which explains in part 
the lack of population-wide data, has important implica-
tions for research on CVD prevalence, risk factors, and out-
comes. The shortage of trained physicians and cardiologists, 
inadequate specialized cardiac facilities and equipment, and 
low levels of education, as well as lack of patient and pub-
lic awareness, may lead to among patients lead many patients 
not having access to basic diagnostic facilities such as elec-
trocardiography and echocardiography, medical therapies 
(eg, streptokinase, β-blockers), and advanced cardiac care. In 
addition, many regions have no access to any form of device 
treatment (eg, pacemaker insertion). The management of the 
communicable forms of CVD such as rheumatic heart disease, 
tuberculous pericarditis, and endomyocardial fibrosis (still 
the most common forms of CVD in many African countries) 
remains suboptimal because of a lack of screening facilities 
such as echocardiography and access to cardiothoracic sur-
gery.31 Standard guidelines, for example, for acute and chronic 
heart failure, are subsequently not implemented, leading to 
poor patient outcome. Recently, the Pan-African Cardiac 
Society has been taking a more active role in context-appro-
priate guideline development and implementation.32 This 
society has representation from southern, eastern, western, 
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and northern Africa and formed recently dedicated working 
groups to address the large burden of hypertension and heart 
failure on the continent.
Implications for Clinical and 
Public Health Action
In an article published in The Lancet under the theme of 
Global Governance for Health, Ottersen and colleagues33 
highlighted that the unacceptable health inequities within 
and between countries globally and in Africa cannot be 
addressed within the health sector alone but require global 
political solutions. Improved global health in return 
increases trade, stability, and prosperity, and it would be 
in the self-interest of the higher-income countries to facili-
tate this process, in addition to the moral imperative.34 
From a local and regional standpoint, however, it must be 
appreciated that the control of many of the risk factors will 
require social and economic engineering, as well as the 
involvement and will of the legislative branch. Such multi-
dimensional approaches are essential to tackle the impor-
tant factors such as second hand smoking, air pollution, 
provision of space, and facilities for exercise and school 
sporting activities. The Republic of the Seychelles, a rap-
idly developing small island state located east to Kenya, 
is a good example that this can be achieved by targeted 
action. Between 1989 and 2010, age-standardized stroke 
and myocardial infarction mortality decreased markedly 
which has been attributed to improved control of persons 
with high blood pressure and diabetes mellitus over time 
as well as increasing leisure time physical activity.35 This 
is remarkable because costly invasive procedures such as 
percutaneous coronary intervention and fibrinolysis are 
used only rarely in the Seychelles. Hence, the lessons to 
be learned from the Seychelles are that collection of good-
quality data on cause-specific mortality and implementa-
tion of good clinical practice such as blood pressure control 
can lead to a reduction in morbidity and mortality.36
It would be of particular importance to get the cooperation 
of industry and food manufacturers to limit the advertising of 
unhealthy food choices, alcohol, and tobacco. In South Africa, 
a large food store has introduced a discount for low-glycemic-
index breads, fruit, and vegetables, thus incentivizing healthy 
food choices. Several medical aid providers offer a discount 
on monthly fees if weight loss has been achieved, sports clubs 
are visited several times a week, and screening for CVD is 
followed by a certain age group. Figure 437 summarizes the 
possible contributing factors to the epidemic of noncommuni-
cable diseases that can be seen in many urban and rural parts 
of Africa and re-emphasizes that only a concerted effort from 
government, industry, and the health sector on both a global 
and a regional basis will stand a chance of telescoping the 
epidemiological transition and the epidemic of CVD in low- 
and middle-income countries, including the African continent.
Table 2 summarizes our recommendations based on the 
WHO “Best Buys” approach. It lists the gaps in knowledge 
and barriers to adequate management of noncommunicable 
diseases in a continent where health professionals’ training 
and healthcare systems are designed to prevent and manage 
endemic communicable diseases such as malaria, tuberculo-
sis, and HIV/AIDS. Because of the limited resources and lack 
of infrastructure for the diagnosis and management of non-
communicable diseases at the primary level, we suggest pos-
sible strategies toward strengthening health systems, focusing 
on 4 major areas: (1) the development of human resources, (2) 
an improvement in infrastructure for diagnosis and manage-
ment of noncommunicable diseases at the primary level, (3) 
implementation of basic registries for mapping of noncom-
municable diseases and risk factors in different populations 
and age groups, and (4) the establishment of partnerships with 
stakeholders outside the health sector.
Mapping of the pattern of noncommunicable diseases will 
be needed to allow health policy makers to increase access 
to diagnostic tools and low-cost generic primary prevention 
medications. Innovative strategies will be needed, building on 
current strategies on task shifting or task sharing in Rwanda38 
and Mozambique,39,40 the results of which are encouraging.
Although thought to further exacerbate income and 
healthcare inequality, industry involvement in promoting 
high-tech imaging, devices, and procedures may be revolu-
tionary. If cost-effective strategies are chosen, directed to the 
relevant problems and tailored to the local conditions, high-
tech tools may be developed both to assess the epidemiol-
ogy and to improve the management of noncommunicable 
diseases in low-resource areas.38 In line with this, African 
Figure 4. Factors contributing to the epidemic 
of cardiovascular disease in low- and middle-
income countries. Adapted from Gersh et al. 
Novel therapeutic concepts: the epidemic of 
cardiovascular disease in the developing world: 
global implications. Eur Heart J. 2010;31:642–
648.37 Copyright © 2010, European Society of 
Cardiology.
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leadership has moved from skepticism to investment in por-
table and battery-powered laboratory devices, training of 
nonspecialists on the use of diagnostic tools and provision 
of care, and promotion of the use of multiplex rapid test sys-
tems at point of care for the assessment of cardiovascular 
risk factors.
Finally, partnerships with the other players in the govern-
ment are essential, for example, interventions and legislation 
for the promotion of healthy food, healthy working environ-
ment and physical activity at workplace.
Conclusions
We have provided evidence that Africa is a continent charac-
terized by marked ethnic, sociodemographic, and economic 
diversity. Profound changes have occurred in many regions 
over the past 2 decades that have had an impact on CVD 
presentation and outcomes. Within Africa and the individual 
countries, one can find regions affected predominantly by 
communicable diseases. Concomitantly, there is an increase in 
the number of areas affected by a marked increase in obesity, 
diabetes mellitus, smoking, and cholesterol. These factors 
lead to a double burden of communicable and noncommuni-
cable disease on the continent.
Poor data and low investment in R&D in almost all African 
countries have resulted in very limited data on CVDs and risk 
factors for most countries, which complicates effective health-
care planning. Therefore, strengthening of health system and 
investment in surveys to describe the pattern of noncommuni-
cable diseases in the continent are mandatory. Collaborative 
programs involving the communities, the industry, and part-
nerships from other sectors of the government would likely 
lead to better overall use of resources and result in national 
and continental growth.
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Table 2. Summary of our Recommendations Based on the WHO “Best Buys” and What Could Be the Way Forward
Gaps in Knowledge and Resources Suggested Next Steps
Reduced pool of trained health workers
  Low rates of graduates from health 
professional schools
  Internal and External brain drain
Use of nonphysician technicians and medical officers for service provision for most prevalent CVD
Train community health workers for primary prevention and early detection of risk factors in the communities
Involve community health workers in support for follow-up of cardiovascular conditions and improvement of 
adherence to medication
Improve salaries for health professionals and academics, and promote career development and other incentives 
for teaching roles
Health system weaknesses in CVD area
  Clinician apathy and lack of continuous 
training
  Lack of routine collection of CVD data
  Low and inconsistent drug availability and 
affordability
  Lack of education and strategies for 
increasing acceptance and adherence to 
long-term therapy
  Insufficient epidemiological data on NCDs 
and risk factors
  Reduced operational research and low 
scientific output
Invest in equitable and high-quality primary care to better detect and manage risk factors such as high blood 
pressure, alcohol abuse, and diabetes mellitus
Implement continuous training of clinicians and nonphysician health providers on prevention and management 
of CVDs
Develop context-specific guidelines and algorithms for risk stratification and medical management of high-risk 
individuals at the primary level
Make lower-cost tests available in low-income settings
Increase access to essential medicines for CVD by defining the minimum package for the primary healthcare 
level and promoting simplified regimens, generic drugs, and combination tablets
Promote systems for cost recovery tailored to the setting and the mode of living of local communities 
Strengthen the routine health information system, imposing compulsory notification of CVD
Lack of comprehensive agenda for CVD 
prevention and control
  Lack of regulatory tools for risk factor 
control
  Health policy decision makers’ inertia to 
legislate toward access to healthy diet and 
good lifestyle
  Lack of population-level strategies for blood 
pressure control
  Unhealthy patient behavior and knowledge 
of prevention of NCD
Incorporate strategies for health education and integrate risk factor control and initial management of CVD into 
primary health care
Regulate toward reduction of caloric intake, use of polyunsaturated fats, and reduction of alcohol consumption
Apply the FCTC provisions aimed at reducing the supply of and demand for tobacco products (eg, ban public 
smoking and increase price of tobacco)
Establish limits on salt for the more commonly used packaged foods and staples such as flour and bread
Promote healthy food choices by taxing unhealthy food choices and improving access to fresh fruits and 
vegetables
Educate the public and health professionals about regular physical activity in urban populations and introduce 
screening for high blood pressure at community level
Impose better planning of cities, creating common open spaces for exercise and active leisure
Promote financial risk protection and universal health coverage
Inadequate infrastructure for research and 
innovation
  Small pool of scientists
  Low investment in R&D infrastructure
  Lack of S&T culture
  Lack of recognition of the scientist’s role
Improve S&T infrastructure as part of poverty alleviation strategies
Implement Africa’s S&T Consolidated Plan of Action
Progressively increase the percent of GDP allocated to R&D
Reduce reliance on external financial support, which often targets short-term goals
Invest in regulation that promotes public-private partnerships on research
Provide incentives to students for engineering and new technologies
CVD indicates cardiovascular disease; FCTC, Framework Convention for Tobacco Control; GDP, gross domestic product; NCD, noncommunicable disease; R&D, 
research and development; S&T, science and technology; and WHO, World Health Organization.
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